- 全部删除
- 您的购物车当前为空
CDK6/PIM1-IN-1 是一种平衡的、有效的、双重 CDK6 (IC50: 39 nM) 和 PIM1 (IC50: 88 nM) 抑制剂。CDK6/PIM1-IN-1 对 CDK4 表现出抑制作用,其 IC50 值为 3.6 nM。CDK6/PIM1-IN-1 能够明显抑制急性髓系白血病 (AML) 细胞增殖,将细胞周期阻滞在 G1 期并诱导细胞凋亡。CDK6/PIM1-IN-1 表现出抗 AML 活性。
CDK6/PIM1-IN-1 是一种平衡的、有效的、双重 CDK6 (IC50: 39 nM) 和 PIM1 (IC50: 88 nM) 抑制剂。CDK6/PIM1-IN-1 对 CDK4 表现出抑制作用,其 IC50 值为 3.6 nM。CDK6/PIM1-IN-1 能够明显抑制急性髓系白血病 (AML) 细胞增殖,将细胞周期阻滞在 G1 期并诱导细胞凋亡。CDK6/PIM1-IN-1 表现出抗 AML 活性。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 10,600 | 6-8周 | |
50 mg | ¥ 13,800 | 6-8周 | |
100 mg | ¥ 17,500 | 6-8周 |
产品描述 | CDK6/PIM1-IN-1 is a balanced, potent, dual CDK6 (IC50: 39 nM) and PIM1 (IC50: 88 nM) inhibitor. CDK6/PIM1-IN-1 showed inhibitory effect on CDK4 with IC50 value of 3.6 nM. CDK6/PIM1-IN-1 can significantly inhibit the proliferation of acute myeloid leukemia (AML) cells, arrest the cell cycle in G1 phase and induce cell apoptosis. CDK6/PIM1-IN-1 showed anti-AML activity. |
靶点活性 | PIM3:92 nM, CDK13/Cyclin K:>10 μM, CDK2/cyclinA:2.274 μM, Cdk4/cyclin D1:3.6 nM, CDK6-CyclinD1:39 nM, CDK3-CyclinE:>10 μM, Cdk5/p25:>10 μM, CDK1/cyclinB:>10 μM, CDK12/Cyclin K:>10 μM, CDK7/Cyclin H/MNAT1:393 nM, CDK9/cyclinT1:440 nM, PIM2:>10 μM, PIM1:88 nM |
分子量 | 473.55 |
分子式 | C25H28FN9 |
CAS No. | 2677026-14-9 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容